140 related articles for article (PubMed ID: 18003813)
1. Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.
Kannangai R; Kandathil AJ; Ebenezer DL; Mathai E; Prakash AJ; Abraham OC; Sudarsanam TD; Pulimood SA; Selvakumar R; Job V; Sridharan G
Clin Vaccine Immunol; 2008 Jan; 15(1):154-8. PubMed ID: 18003813
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 clade C infection and progressive disruption in the relationship between cortisol, DHEAS and CD4 cell numbers: a two-year follow-up study.
Chittiprol S; Kumar AM; Shetty KT; Kumar HR; Satishchandra P; Rao RS; Ravi V; Desai A; Subbakrishna DK; Philip M; Satish KS; Kumar M
Clin Chim Acta; 2009 Nov; 409(1-2):4-10. PubMed ID: 19576195
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of hemoglobin and albumin as prognostic markers for highly active antiretroviral therapy for HIV-1 infection.
Chauhan NK; Vajpayee M; Singh A
Indian J Med Sci; 2011 Jul; 65(7):286-96. PubMed ID: 23422702
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus infection and levels of Dehydroepiandrosterone sulfate in plasma among Indians.
Kandathil AJ; Kannangai R; David S; Selvakumar R; Job V; Abraham OC; Sridharan G
Clin Diagn Lab Immunol; 2005 Sep; 12(9):1117-8. PubMed ID: 16148181
[TBL] [Abstract][Full Text] [Related]
5. Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection.
Swaminathan S; Hu Z; Rupert AW; Higgins JM; Dewar RL; Stevens R; Chen Q; Rehm CA; Metcalf JA; Baseler MW; Lane HC; Imamichi T
PLoS One; 2014; 9(6):e98989. PubMed ID: 24896094
[TBL] [Abstract][Full Text] [Related]
6. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year.
Ferrando SJ; Rabkin JG; Poretsky L
J Acquir Immune Defic Syndr; 1999 Oct; 22(2):146-54. PubMed ID: 10843528
[TBL] [Abstract][Full Text] [Related]
8. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
[TBL] [Abstract][Full Text] [Related]
9. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
[TBL] [Abstract][Full Text] [Related]
10. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
[TBL] [Abstract][Full Text] [Related]
12. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
13. CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus.
Bishop JD; DeShields S; Cunningham T; Troy SB
Am J Med Sci; 2016 Sep; 352(3):239-44. PubMed ID: 27650226
[TBL] [Abstract][Full Text] [Related]
14. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
15. Early syphilis affects markers of HIV infection.
Kotsafti O; Paparizos V; Kourkounti S; Chatziioannou A; Nicolaidou E; Kapsimali V; Antoniou C
Int J STD AIDS; 2016 Aug; 27(9):739-45. PubMed ID: 26113517
[TBL] [Abstract][Full Text] [Related]
16. Correlation of baseline quantitative plasma human immunodeficiency (HIV) type 1 RNA viral load with clinical status and CD4+ T-cell counts in treatment-naïve HIV-positive patients in Singapore.
Ho BC; Laudette-Aboulhab J; Se-Thoe SY; Chan SP; Ling AE; Leo YS
Ann Acad Med Singap; 2000 Nov; 29(6):708-13. PubMed ID: 11269974
[TBL] [Abstract][Full Text] [Related]
17. Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profile.
Schifitto G; McDermott MP; Evans T; Fitzgerald T; Schwimmer J; Demeter L; Kieburtz K
Arch Neurol; 2000 Jul; 57(7):1027-32. PubMed ID: 10891985
[TBL] [Abstract][Full Text] [Related]
18. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
20. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
